Taylor & Francis Group
Browse

Neoadjuvant treatment and survival outcomes by pathologic complete response in HER2-negative early breast cancers. Supplementary materials.

figure
posted on 2023-03-28, 08:34 authored by Anagha Gogate, Catherine Davis, Felipe Ades, Rolee Das, Le Kim Trong, Amanda Crosbie, Ying Zhang

supplementary figures and tables

History